| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A high cardiothoracic ratio increases the risk of severe pulmonary complications after early initiation of clazosentan in patients with aneurysmal subarachnoid hemorrhage
|
Nishii, Rikuo
|
|
|
5 |
2 |
p. 85-90
|
article
|
| 2 |
Beneficial effects of clazosentan add-on treatment on delayed cerebral microcirculatory disturbances after aneurysmal subarachnoid hemorrhage
|
Suzuki, Hidenori
|
|
|
5 |
2 |
p. 62-68
|
article
|
| 3 |
Clazosentan, first approval in Japan: Has perioperative management of subarachnoid hemorrhage changed?
|
Suzuki, Hidenori
|
|
|
5 |
2 |
p. 53-54
|
article
|
| 4 |
Could clazosentan, first approved in Japan, improve neurological prognosis after subarachnoid hemorrhage in combination with modified water-electrolyte management?
|
Shikata, Eiji
|
|
|
5 |
2 |
p. 91-97
|
article
|
| 5 |
Evolving approaches in the management of patients with subarachnoid hemorrhage from 2002 to 2022: The impact of clazosentan and treatment modalities on outcomes
|
Maeda, Hajime
|
|
|
5 |
2 |
p. 55-61
|
article
|
| 6 |
Fluid balance management with loop diuretics in patients with aneurysmal subarachnoid hemorrhage treated with clazosentan: A case series
|
Akamatsu, Yosuke
|
|
|
5 |
2 |
p. 74-78
|
article
|
| 7 |
Impact of strict fluid management on the treatment outcome of clazosentan for cerebral vasospasm
|
Itazu, Takaaki
|
|
|
5 |
2 |
p. 69-73
|
article
|
| 8 |
Initial results of clazosentan with multiple-drug management for the prevention of cerebral vasospasm after aneurysmal subarachnoid hemorrhage
|
Kimura, Tatsuki
|
|
|
5 |
2 |
p. 79-84
|
article
|
Journal description